Cherelyn Vella

488 total citations
23 papers, 376 citations indexed

About

Cherelyn Vella is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Cherelyn Vella has authored 23 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Virology, 9 papers in Infectious Diseases and 6 papers in Epidemiology. Recurrent topics in Cherelyn Vella's work include HIV Research and Treatment (14 papers), Cytomegalovirus and herpesvirus research (6 papers) and HIV/AIDS drug development and treatment (6 papers). Cherelyn Vella is often cited by papers focused on HIV Research and Treatment (14 papers), Cytomegalovirus and herpesvirus research (6 papers) and HIV/AIDS drug development and treatment (6 papers). Cherelyn Vella collaborates with scholars based in United Kingdom, China and Germany. Cherelyn Vella's co-authors include Zhengtao Wang, S. W. Annie Bligh, H Festenstein, C. Branford-White, Songshan Shi, R. S. Daniels, C. L. Brown, D. McCarthy, Philip D. Minor and Rodney S. Daniels and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, AIDS and International Journal of Biological Macromolecules.

In The Last Decade

Cherelyn Vella

22 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cherelyn Vella United Kingdom 11 139 98 90 80 78 23 376
Edmundo N. Kraiselburd Puerto Rico 9 74 0.5× 104 1.1× 100 1.1× 89 1.1× 70 0.9× 17 344
Garry Lund Canada 12 37 0.3× 75 0.8× 66 0.7× 16 0.2× 232 3.0× 21 501
T Matsui Japan 9 236 1.7× 239 2.4× 79 0.9× 11 0.1× 117 1.5× 18 560
Xia Chen China 13 32 0.2× 36 0.4× 330 3.7× 65 0.8× 51 0.7× 28 537
Maria Ekblad Sweden 12 21 0.2× 30 0.3× 78 0.9× 29 0.4× 147 1.9× 15 368
Vanessa Danielle Menjon Müller Brazil 9 22 0.2× 73 0.7× 109 1.2× 11 0.1× 30 0.4× 10 405
Mustapha Hajjou United States 10 12 0.1× 88 0.9× 32 0.4× 25 0.3× 78 1.0× 12 360
Nicolás Corrales Chile 7 18 0.1× 33 0.3× 88 1.0× 14 0.2× 162 2.1× 11 300
Francielle Tramontini Gomes de Sousa Brazil 9 14 0.1× 115 1.2× 47 0.5× 19 0.2× 43 0.6× 12 354
Sarah L. Grady United States 5 28 0.2× 64 0.7× 109 1.2× 3 0.0× 179 2.3× 8 410

Countries citing papers authored by Cherelyn Vella

Since Specialization
Citations

This map shows the geographic impact of Cherelyn Vella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cherelyn Vella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cherelyn Vella more than expected).

Fields of papers citing papers by Cherelyn Vella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cherelyn Vella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cherelyn Vella. The network helps show where Cherelyn Vella may publish in the future.

Co-authorship network of co-authors of Cherelyn Vella

This figure shows the co-authorship network connecting the top 25 collaborators of Cherelyn Vella. A scholar is included among the top collaborators of Cherelyn Vella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cherelyn Vella. Cherelyn Vella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hudson, Harry R., et al.. (2013). Enhanced Replication of R5 HIV‐1 Isolates in vitro by a Small‐Molecule Reagent Targeting HIV‐1 Protease. ChemMedChem. 8(5). 719–721. 3 indexed citations
2.
Yan, Jun, Shunchun Wang, Lili Ji, et al.. (2012). Antiangiogenic effects of GFP08, an agaran-type polysaccharide isolated from Grateloupia filicina. Glycobiology. 22(10). 1343–1352. 33 indexed citations
3.
Vella, Cherelyn, et al.. (2009). Arachidonic and Docosahexaenoic Acid Deficits in Preterm Neonatal Mononuclear Cell Membranes. Implications for the Immune Response at Birth. Nutrition and Health. 20(2). 167–185. 9 indexed citations
4.
Bligh, S. W. Annie, et al.. (2007). Structural features and anti-HIV-1 activity of novel polysaccharides from red algae Grateloupia longifolia and Grateloupia filicina. International Journal of Biological Macromolecules. 41(4). 369–375. 76 indexed citations
5.
Vella, Cherelyn & Rodney S. Daniels. (2003). CD8+ T-cell-mediated Non-cytolytic Suppression of Human Immunodeficiency Viruses. PubMed. 3(2). 97–113. 11 indexed citations
6.
Novelli, Patricia, Cherelyn Vella, Julia Thom Oxford, & R. S. Daniels. (2002). Construction and Characterization of a Full-Length HIV-1 92UG001 Subtype D Infectious Molecular Clone. AIDS Research and Human Retroviruses. 18(1). 85–88. 7 indexed citations
7.
Vella, Cherelyn, et al.. (2002). Herpesvirus saimiri-Immortalized Human Lymphocytes: Novel Hosts for Analyzing HIV Type 1 in Vitro Neutralization. AIDS Research and Human Retroviruses. 18(13). 933–946. 5 indexed citations
8.
9.
Shaw, T R, Neil Berry, Cherelyn Vella, et al.. (2001). Antiretroviral Therapy for HIV-2 Infected Patients. Journal of Infection. 42(2). 126–133. 45 indexed citations
10.
Novelli, Patricia, Cherelyn Vella, Julia Thom Oxford, & Rodney S. Daniels. (2000). Construction and Biological Characterization of an Infectious Molecular Clone of HIV Type 1 GB8. AIDS Research and Human Retroviruses. 16(12). 1175–1178. 4 indexed citations
11.
Vella, Cherelyn, et al.. (1999). Alterations in the V1/V2 Domain of HIV-2 CBL24 Glycoprotein 105 Correlate with an Extended Cell Tropism. AIDS Research and Human Retroviruses. 15(15). 1399–1402. 6 indexed citations
12.
Vella, Cherelyn, et al.. (1999). Enhanced replication of M-tropic HIV-1 strains in Herpesvirus saimiri immortalised T-cells which express CCR5. Journal of Virological Methods. 79(1). 51–63. 14 indexed citations
13.
Vella, Cherelyn, R. S. Daniels, Mary E. Penny, Clarke E. Atkins, & Helmut Fickenscher. (1997). Herpesvirus saimiri-immortalized human T-cells support long-term, high titred replication of human immunodeficiency virus types 1 and 2.. Journal of General Virology. 78(6). 1405–1409. 14 indexed citations
14.
Vella, Cherelyn. (1995). A molecular and serologic study of the envelope gene of the British isolate: HIV-1 GB8. Vaccine. 13(8). 735–741. 8 indexed citations
15.
Vella, Cherelyn, Michael A. J. Ferguson, G. Dunn, et al.. (1993). Characterization and primary structure of a human immunodeficiency virus type 1 (HIV-1) neutralization domain as presented by a poliovirus type 1/HIV-1 chimera. Journal of General Virology. 74(12). 2603–2607. 32 indexed citations
16.
Vella, Cherelyn & H Festenstein. (1992). Coxsackievirus B4 infection of the mouse pancreas: the role of natural killer cells in the control of virus replication and resistance to infection. Journal of General Virology. 73(6). 1379–1386. 21 indexed citations
17.
Vella, Cherelyn, C. L. Brown, & D. McCarthy. (1992). Coxsackievirus B4 infection of the mouse pancreas: acute and persistent infection. Journal of General Virology. 73(6). 1387–1394. 27 indexed citations
18.
Page, Mark, Cherelyn Vella, T. Corcoran, et al.. (1992). Restriction of serum antibody reactivity to the V3 neutralizing domain of HIV gp120 with progression to AIDS. AIDS. 6(5). 441–446. 10 indexed citations
19.
Vella, Cherelyn, Andrew J. Easton, Roger Eglin, C. L. Brown, & Lesley Perry. (1991). Coxsackie virus B4 infection of the mouse pancreas: I. Detection of virus‐specific rna in the pancreas by in situ hybridization. Journal of Medical Virology. 35(1). 46–49. 2 indexed citations
20.
Vella, Cherelyn, et al.. (1991). Recognition of poliovirus/HIV chimaeras by antisera from individuals with HIV infection. AIDS. 5(4). 425–430. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edmundo N. Kraiselburd Breakdown of academic impact, for papers by Garry Lund Breakdown of academic impact, for papers by T Matsui Breakdown of academic impact, for papers by Xia Chen Breakdown of academic impact, for papers by Maria Ekblad Breakdown of academic impact, for papers by Vanessa Danielle Menjon Müller Breakdown of academic impact, for papers by Mustapha Hajjou Breakdown of academic impact, for papers by Nicolás Corrales Breakdown of academic impact, for papers by Francielle Tramontini Gomes de Sousa Breakdown of academic impact, for papers by Sarah L. Grady
Rankless by CCL
2026